Chunghwa Chemical Synthesis & Biotech

About Chunghwa Chemical Synthesis & Biotech

Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB), founded in 1964, is one of the largest API manufacturers in Taiwan. CCSB is a FDA /EU approved cGMP API plant to produce synthesis and biotechnology products. CCSB has filed US DMF, EDMF and COS for several products. Our products include Mycophenolate Mofetil, Rapamycin (Sirolimus), Tacrolimus Monohydrate, Everolimus, Caspofungin Acetate , etc. CCSB also offers contract manufacturing in the cGMP plants. Currently, CCSB is making APIs for European clients under contract and supplying intermediates to new drug companies.

  • TW
  • 2015
    On CPHI since
  • 250 - 499
    Employees
Company types
CMO/CDMO
Pharmaceutical company
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022

Products from Chunghwa Chemical Synthesis & Biotech (5)

  • Everolimus

    Product Everolimus

    Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes everolimus. It belongs to immunosuppressant and oncology category. Contact us for more information.
  • Rapamycin

    Product Rapamycin

    Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes rapamycin. It belongs to immunosuppressant category. Contact us for more information.
  • Tacrolimus

    Product Tacrolimus

    Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes tacrolimus. It belongs to immunosuppressant category. Contact us for more information.
  • Caspofungin Acetate

    Product Caspofungin Acetate

    Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes caspofungin acetate. It belongs to antifungal category. Contact us for more information.
  • Ethyl Icosapentate

    Product Ethyl Icosapentate

    Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes ethyl icosapentate. Contact us for more information.